B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HSP90AB1

MOLECULAR TARGET

heat shock protein 90 alpha family class B member 1

UniProt: AAD14062NCBI Gene: 332616 compounds

HSP90AB1 (heat shock protein 90 alpha family class B member 1) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HSP90AB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1triolimus [Supplementary Concept]4.2569
219-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]3.9953
3monorden3.0420
4gedunin2.309
5celastrol2.208
6Novobiocin1.393
7caffeic acid1.102
8Masoprocol1.102
9Tetracycline1.102
10Zearalenone (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradec in-1,7(8H)-dione.1.102
11myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
12Quercetin0.691
13ag4900.691
14Idarubicin0.691
15piceatannol0.691
16Nitroprusside0.691

About HSP90AB1 as a Drug Target

HSP90AB1 (heat shock protein 90 alpha family class B member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented HSP90AB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HSP90AB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.